Streetbeat News

Stock Prices

AZN

GMAB

JNJ

MRUS

AstraZeneca's Phase 3 FLAURA2 results for Tagrisso plus chemotherapy as a first-line treatment for EGFR mutant lung cancer showed significant benefits, setting a high bar for Johnson & Johnson's MARIPOSA Phase 3 trial. Genmab, which receives royalties on Rybrevant sales, and Merus, which has potential benefits from the development of petosemtamab, are also impacted by these developments.

Portfolio Pulse from Vandana Singh

September 11, 2023 | 6:31 pm

WMT

A significant investor has taken a bearish stance on Walmart (NYSE:WMT), with 53% of recent trades being bearish and 46% bullish. The targeted price range for Walmart over the last 3 months has been $80.0 to $175.0. The current price of WMT is $164.0, up 0.14%, and RSI indicators suggest the stock may be approaching overbought. Analysts from Truist Securities, Citigroup, Stifel, Baird, and Goldman Sachs have maintained their ratings on Walmart, with price targets ranging from $167 to $182.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 6:31 pm

UNH

A significant bearish stance has been taken on UnitedHealth Group (NYSE:UNH) as indicated by unusual options activity. The sentiment among big-money traders is split between 42% bullish and 57% bearish. Whales have been targeting a price range from $470.0 to $580.0 for UnitedHealth Group over the last 3 months. HSBC has downgraded its action to Hold with a price target of $540.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 6:31 pm

BIDU

Baidu (NASDAQ:BIDU) has outperformed the market over the past 15 years, producing an average annual return of 16.9%. If an investor had bought $100 of BIDU stock 15 years ago, it would be worth $1,016.04 today.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 6:30 pm

MSI

Motorola Solns (NYSE:MSI) has outperformed the market over the past 15 years, producing an average annual return of 16.36%. If an investor had bought $1000 of MSI stock 15 years ago, it would be worth $9,181.85 today.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 6:30 pm

NFLX

Netflix's stock price experienced significant fluctuations between November 2021 and May 2022, dropping 75% to a low of $162. However, the stock showed resilience, maintaining above $162 for two months before rebounding and surpassing $200 in late July 2022. By June 2023, the stock reached over $400. Despite some resistance, the stock has shown positive momentum, with a year-to-date gain of 47%. The future of Netflix's stock price looks promising, with the $500 mark emerging as the next significant resistance level.

Portfolio Pulse from Zaheer Anwari

September 11, 2023 | 6:30 pm

BCYC

Bicycle Therapeutics announced an expedited development plan for BT8009, leading to a rise in its share prices. B. Riley Securities upgraded the stock from Neutral to Buy.

Portfolio Pulse from Bill Haddad

September 11, 2023 | 6:24 pm

FLWS

Shares of 1-800-FLOWERS.COM are trading higher following the disclosure of stock purchases by the company's President and CFO.

Portfolio Pulse from Bill Haddad

September 11, 2023 | 6:19 pm

SMRT

SmartRent, Inc. (NYSE:SMRT) has responded to a recent short-seller report, calling it inaccurate and misleading. The report made negative conclusions based on RET Ventures' reduced holdings of SmartRent stock, which the company clarified was due to a series of pro rata, in-kind distributions typical of private venture funds. SmartRent maintains a close business relationship with RET and its limited partners remain SmartRent customers. The company stands by the security of its products and the value provided to property owners, managers, and residents.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2023 | 6:18 pm

LVS

A significant bullish stance has been taken on Las Vegas Sands (NYSE:LVS) by a large investor or institution, as indicated by a large position appearing in publicly available options history. The overall sentiment of these big-money traders is split between 63% bullish and 36% bearish. Whales have been targeting a price range from $45.0 to $62.5 for Las Vegas Sands over the last 3 months. The price of LVS is currently down -0.03% at $48.85, and RSI indicators suggest the stock may be oversold.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 6:16 pm